Insulin lispro-aabc

FDA Drug Profile — LYUMJEV, LYUMJEV KwikPen, LYUMJEV Tempo Pen, LYUMJEV Junior KwikPen

Drug Details

Generic Name
Insulin lispro-aabc
Brand Names
LYUMJEV, LYUMJEV KwikPen, LYUMJEV Tempo Pen, LYUMJEV Junior KwikPen
Application Number
BLA761109
Sponsor
Eli Lilly and Company
NDC Codes
13
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN LISPRO

Indications and Usage

1 INDICATIONS AND USAGE LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )